Latest News
Beginning of public review and comment period on OEHHA's interpretive guideline on how to estimate lead intake from the handling of consumer products in the context of Proposition 65.
Adoption of 0.54 micrograms per day as the No Significant Risk Level for glycidol for purposes of Proposition 65.
The hazard identification document entitled: “Evidence on the Developmental and Reproductive Toxicity of Sulfur Dioxide" is available for public comment. The DART IC meeting is scheduled for May 12 and 13, 2011.
Availability for public review of the hazard identification document entitled: “Evidence on the Developmental and Reproductive Toxicity of Sulfur Dioxide."
OEHHA adds acrylamide (CAS No. 79-06-1) to the list of chemicals known to the state to cause reproductive toxicity
Approved amendment to Title 27, California Code of Regulations, section 25705(b)(1), that adopt 8.2 micrograms per day as the No Significant Risk Level for 2,4,6-Trinitrotoluene (TNT) for purposes of Proposition 65.
Extension of comment period for the proposal to establish a specific regulatory level posing no significant risk for 4-methylimidazole by amending Title 27, California Code of Regulations, section 25705.
Announcement of chemicals selected in 2011 by OEHHA for consideration for listing by the Carcinogen Identification Committee and request for relevant information on the carcinogenic hazards of these chemicals: clomiphene and its salts, 2,6-dimethyl-N-nitrosomorpholine, haloperidol, tris(1,3-dichloro-2-propyl) phosphate (TDCPP).
2011 public comment period on the Carcinogenic Hazards of: Clomiphene and its salts, 2,6-Dimethyl-N-nitrosomorpholine, Haloperidol, Tris(1,3-dichloro-2-propyl) phosphate (TDCPP)